Ba. Faraj et al., ACTIVE [H-3] DOPAMINE UPTAKE BY HUMAN-LYMPHOCYTES - CORRELATES WITH SEROTONIN TRANSPORTER ACTIVITY, Pharmacology, 48(5), 1994, pp. 320-327
The main objective of the present investigation was to determine wheth
er the uptake ofH-3-dopamine in human lymphocytes is mediated throug
h a serotonin transporter. This was examined by studying the effects o
f various monoamine uptake inhibitors on the uptake of H-3-dopamine
in human lymphocytes. Among the compounds tested, indatraline, imipram
ine and fluoxetine, selective inhibitors of neuronal serotonin transpo
rter, were the most potent inhibitors of H-3, dopamine uptake in lym
phocytes. The 50% inhibiting concentration (IC50) for these inhibitors
was in the range of 3.5-17 nmol/l. Bupropion, GBR 12909, nomifensine
and xylamine, selective inhibitors of dopamine and norepinephrine tran
sporters, had low affinity for the dopamine uptake system in human lym
phocytes with IC50 values ranging between 1,000 and 40,000 nmol/l. The
se findings provide supportive evidence for the participation of a ser
otonin transporter in the uptake of H-3-dopamine in human lymphocyte
s. The existence of a high affinity transport system for dopamine and
serotonin in human lymphocytes may serve as a readily accessible model
to detect changes in the neuronal uptake of dopamine and serotonin in
addictive and psychiatric disorders.